Skip to content

Role of Automated Plantar Foot Stimulation on Balance and Gait Functions in Patient with Multiple Sclerosis

Effect of Automated Plantar Foot Stimulation on Balance and Gait Performance in Patient with Multiple Sclerosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202409748500764
Enrollment
45
Registered
2024-09-02
Start date
2024-08-23
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

Automated Plantar Foot Stimulation Device
Vibrating Insole
Therapeutic Exercises program

Sponsors

Faculty of Physical Therapy Cairo university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Forty-five multiple sclerosis patients from both sexes will participate in this study. 2) Their BMI ranges between 18.5 and 24.9. 3) Age of patient range from 25-45 years old . 4) Clinically definite Ataxic Multiple Sclerosis (relapsing and remitting) patients who are stable for at least three months 5) Duration of illness started “one" to "two" years ago. 6) Duration of immune regulatory therapy " one" to "two" years. 7) Patients with sufficient cognitive abilities that enables them to understand and follow instructions (Mini-Mental Scale >24) . 8) Ambulant patients with Expanded disability status scale of each patient ranged between 1.0 and4.5

Exclusion criteria

Exclusion criteria: 1) Any other neurological deficits or orthopedics abnormalities such as contracture or deformities. 2) Any other inflammatory or infectious diseases, in the previous month e.g., arthritis. 3) Pregnant patients. 4) Cardiovascular and Pulmonary diseases. 5) Patients in acute relapse stage. 6) Patients with any psychiatric disease.

Design outcomes

Primary

MeasureTime frame
Changes in step length from baseline to 12 weeks after the beginning of intervention 2D gait analysis for assessment;Changes in Angle of dorsiflexion from baseline to 12 weeks after the beginning of intervention 2D gait analysis for assessment;Changes in step Time from baseline to 12 weeks after the beginning of intervention 2D gait analysis for assessment

Secondary

MeasureTime frame
Changes in Overall stability index from baseline to 12 weeks after the beginning of intervention Biodex balance system for assessment;Changes in Antero-posterior stability index from baseline to 12 weeks after the beginning of intervention biodex balance system for assessment;Changes in Medio-lateral stability index from baseline to 12 weeks after the beginning of intervention biodex balance system for assessment

Countries

Egypt

Contacts

Public ContactMohamed Emam

Assistant Lecturer

mohamedtarekemam@pt.cu.edu.eg0201060653336

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026